Grape pomace (GP), a by-product of winemaking, is rich in polyphenols and fiber, making it a promising and sustainable feed supplement for ruminants. This study evaluated the safety and productive impact of a 5% GP-supplemented diet (GP5) including non-lactating end-cycle (EC) ewes regularly destined for slaughter and human consumption, and lactating (LAC) ewes, over a 30-day period. Control (CTRL) animals received a standard pellet diet with no GP inclusion. Sampling was performed at four time points (T0, T10, T20, and T30), corresponding to days 0, 10, 20, and 30 of the experimental period. The study assessed clinical status, hematology/biochemistry (T0 and T30), milk composition (T0, T10, T20, and T30), meat quality traits and oxidative stability in EC ewes (T30). Since no significant differences were observed in the CTRL animals, the effects were evaluated within the GP5 group by comparing T0 vs. T30. Meat quality was assessed by comparing EC-GP5 to CTRL at T30. The GP extract showed a high total phenolic content (254.02 ± 20.39 mg GAE/g DW). No clinical or hematological alterations were observed, and most values remained within physiological ranges. Biochemical analysis revealed significant increases in albumin, bilirubin, creatinine, and triglycerides (p < 0.05), with significant decreases in plasma urea and glucose (p < 0.05). In LAC-GP5 ewes, milk urea and lactose concentrations decreased (p < 0.05), while pH increased (p < 0.05), with no significant changes in fat or casein content. These findings are consistent with reduced ruminal propionate availability, leading to decreased hepatic gluconeogenesis and lactose synthesis, with secondary effects on nitrogen metabolism and the acid–base profile of milk. In EC-GP5 ewes, meat quality traits were unaffected, and DPPH scavenging activity did not differ from CTRL (p > 0.05). GP5 was metabolically safe, induced adaptive changes in milk composition, and had no negative effects on meat quality, supporting the valorization of grape pomace as a sustainable feed resource. This trial was designed as a metabolic safety assessment, representing a preliminary step toward future mechanistic and molecular investigations.

Aging involves progressive physiological changes, including the dysregulation of water homeostasis, essential for cellular function, neuronal signaling, and musculoskeletal integrity. This review explores the emerging role of water loss as a central and underestimated driver of functional decline in aging, with a focus on the dog, both as a clinically relevant target species and as a model for human aging. Age-related alterations in water metabolism—driven by changes in body composition, aquaporin (AQP) expression, electrolyte imbalances, reduced thirst perception, and impaired urine concentration—lead to intracellular and extracellular dehydration, exacerbating functional decline. We examine molecular mechanisms of water regulation involving AQPs and osmolytes, and describe how dehydration contributes to structural and metabolic dysfunction across key biological compartments, including the kidney, brain, bone, and skeletal muscle. Physiological dehydration, a hallmark of aging, intensifies inflammaging, accelerating tissue degeneration. In particular, we highlight how water loss impairs solvent capacity, solute transport, protein conformation, and cellular communication. Despite the known role of macronutrients in geriatric nutrition, hydration remains an often-overlooked factor in aging management. We argue for its inclusion as a fourth pillar in the nutritional approach to veterinary geriatrics, alongside protein, fat, and fiber. By investigating aging-associated water loss in dogs—species that share environments and lifestyle patterns with humans—we propose hydration-centered strategies to promote healthy aging in both veterinary and comparative medicine.

Osteoarthritis (OA) is increasingly conceptualized as a whole-joint disorder, in which pathological processes across articular cartilage, subchondral bone, synovium, and periarticular tissues are tightly interconnected. Within this context, miRNAs have emerged as central post-transcriptional regulators capable of integrating mechanical, inflammatory, and metabolic cues at the network level. In human OA, extensive evidence links miRNA dysregulation to cartilage catabolism, impaired stress adaptation, inter-tissue communication, and the emergence of extracellular and circulating miRNA (cmiRNA) signatures with diagnostic and translational relevance. In contrast, miRNA research in canine OA remains limited, despite dogs developing a naturally occurring form of the disease that closely mirrors human OA in clinical presentation, joint pathology, and biomechanical drivers. To date, only a single pilot study has systematically investigated miRNA expression in spontaneous canine OA, underscoring both the feasibility of miRNA profiling and the substantial gaps that persist in tissue validation and functional characterization. This review critically synthesizes miRNA-mediated regulatory mechanisms in human OA and leverages this evidence to define research priorities in canine OA, where experimental validation remains limited. By focusing on shared molecular contexts rather than assumed equivalence, the review defines a comparative framework highlighting cmiRNAs as promising non-invasive translational targets.

Grape pomace (GP) is being explored as a sustainable feed ingredient for ruminants due to its fiber and polyphenol content; however, its systemic effects under farming conditions remain unclear. This study tested whether 5% dried grape pomace (GP5) modulates serum circulating miRNAs (cmiRNAs) in dairy sheep. Twelve Sarda ewes were enrolled in a 30-day trial and assigned to a control (CTRL) or GP5 diet. Small RNA sequencing was initially performed in GP5 animals (paired T30 vs. T0 comparison); after quality filtering, five paired animals were included in the sequencing analyses. The differentially expressed (DE) cmiRNAs were validated by RT-qPCR in GP5 and CTRL groups. RT-qPCR confirmed the NGS-derived miRNA signature, identifying miR-143, miR-382-5p, miR-409-3p, and miR-194 as significantly downregulated (p < 0.05) in GP5 animals. Ingenuity Pathway Analysis (IPA) showed that DE miRNAs target shared hubs, with PPAR signaling among the most enriched pathways (BH-adjusted p = 1.35 × 10⁻⁹), predicted to be inhibited (Z = −2.646). Cholecystokinin/gastrin-mediated and S100 signaling were also enriched (BH-adjusted p = 7.08 × 10⁻¹¹ and 3.21 × 10⁻⁸) and predicted to be activated (Z = 2.828 and 3.162). Overall, GP5 supplementation was associated with a selective cmiRNA signature consistent with targeted post-transcriptional regulation.

Background: Osteoarthritis (OA) is a chronic whole-joint disease involving extracellular matrix remodeling, inflammatory signaling, immune–stromal interactions, and sensory-associated processes. MicroRNAs (miRNAs) may contribute to post-transcriptional regulation within these interconnected molecular domains, but concurrent mRNA and miRNA expression patterns remain insufficiently characterized in naturally occurring canine OA. Methods: A total of 12 formalin-fixed, paraffin-embedded (FFPE) canine tissue specimens were classified as osteoarthritic joint tissues (OA; n = 7) and control joint tissues without radiographic or histopathological evidence of OA (C-JT; n = 5). RT-qPCR was used to quantify 17 selected mRNAs involved in extracellular matrix remodeling, chronic inflammatory signaling, immune–stromal interactions, and neuroinflammatory and sensory-associated processes, together with five miR-30 family members. Statistical comparisons were performed on ΔCq values using two-sided unpaired Welch’s t-tests followed by Benjamini–Hochberg false discovery rate correction. Results: Compared with C-JT, OA tissues showed significantly higher expression of ADAMTS5, MMP2, MMP13, COL2A1, SPARC, HP, VEGFA, IGFBP6, and ASIC3 after false discovery rate correction. MMP9, IL1B, IL1R1, IL1RAP, JAK2, TYK2, NGFB, and NTRK1 did not differ significantly between the two joint-tissue groups. MiR-30b was significantly downregulated in OA, whereas miR-30c, miR-30d, and miR-30e were significantly upregulated; miR-30a did not differ significantly. Exploratory database-supported miRNA–gene connectivity was used for candidate prioritization but was not interpreted as evidence of direct regulation in canine joint tissue. Conclusions: Canine osteoarthritic capsulosynovial tissues exhibit concurrent alterations in selected mRNAs and miR-30 family members across matrix-remodeling, immune–stromal, and sensory-associated molecular domains. These findings identify OA-associated expression patterns but do not establish pathway activation, direct miRNA–mRNA regulation, or disease progression. They provide a focused molecular basis for future mechanistic studies of post-transcriptional regulation in naturally occurring canine OA.

Introduction: Intra-articular (IA) administration of local anaesthetic drugs has been widely reported in shoulder, elbow, ankle and knee arthroscopy in human medicine. The use of IA adrenaline to control bleeding in arthroscopy is relatively common, but its combined effect with local anaesthetics on perioperative pain has not been studied in dogs. This study aims at evaluating the efficacy of IA shoulder administration of lidocaine or lidocaine plus adrenaline in dogs (Canis lupus familiaris) as pre-emptive analgesia during arthroscopic surgery under general anaesthesia. Methods: Twenty-four dogs were randomly assigned to receive a bolus of lidocaine 2% (group L), a mixture of lidocaine and adrenaline (group LA) or saline solution (NaCl 0.9%) (Control group-group C), injected into a shoulder joint before arthroscopic surgery. Haemodynamic and respiratory parameters were recorded at scheduled times: Baseline (B) at stable anaesthesia and before the painful stimuli; joint injection (J) and 5, 10, 15 minutes post J; trocar insertion (T) and 5, 10, 20, 30, 45, 60 minutes post T. If at least one of the baseline parameters among heart rate, respiratory rate and indirect systolic blood pressure increased by more than 20%, a bolus of 0.2 μg/kg of sufentanil was administered intravenously as rescue analgesia. Results: Results of this study show that the total dose of sufentanil and the number of boluses required during surgery were significantly lower in group L [odds ratio 6.28 (95% CI: 2-07–18.98)] and LA [odds ratio 8.45 (95% CI: 2.44–29.27)] compared to group C. In group LA, the time of first sufentanil bolus administration was significantly delayed compared to the other two groups. Significant differences in the variability of haemodynamic parameters were observed for HR ( p = < 0.001), DAP ( p = 0.041), RR ( p = 0.013) at T0 (Baseline, before treatment). These findings indicate greater parameter variability in dogs of Group C (control group) compared with the other groups. Discussion/Conclusion: Compared with placebo, intra articular administration of lidocaine or lidocaine combined with adrenaline just before shoulder arthroscopic surgery in dogs reduces the intraoperative requirement for sufentanil, indicating that this local analgesic approach contributes effectively to a multimodal analgesic protocol.